Pacira BioSciences, Inc. (PCRX) Social Stream



Pacira BioSciences, Inc. (PCRX): $28.65

0.65 (+2.32%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add PCRX to Watchlist
Sign Up

PACIRA BIOSCIENCES INC (PCRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering PACIRA BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 12 $93 $54 $80.916 $32.65 147.83%
2021-12-08 12 $93 $54 $81.083 $32.65 148.34%
2021-12-10 12 $97 $54 $81.416 $32.65 149.36%
2022-01-07 13 $97 $54 $81.538 $32.65 149.73%
2022-01-13 13 $97 $54 $81.846 $32.65 150.68%
2022-02-25 13 $97 $54 $82.384 $32.65 152.32%
2022-03-01 13 $96 $54 $82.615 $32.65 153.03%
2022-04-14 11 $96 $54 $81.363 $32.65 149.2%
2022-05-05 11 $96 $54 $80.545 $32.65 146.69%
2022-05-13 10 $96 $54 $81.6 $32.65 149.92%
2022-06-01 9 $96 $54 $83.222 $32.65 154.89%
2022-06-15 8 $96 $54 $82.125 $32.65 151.53%
2022-07-21 8 $96 $54 $81.625 $32.65 150%
2022-08-01 8 $96 $54 $81.125 $32.65 148.47%
2022-08-02 8 $96 $54 $80.75 $32.65 147.32%
2022-08-04 8 $96 $54 $80.142 $32.65 145.46%
2022-09-21 8 $96 $54 $80.125 $32.65 145.41%
2022-10-13 7 $96 $54 $80.125 $32.65 145.41%
2022-10-17 8 $96 $54 $79.25 $32.65 142.73%
2022-11-02 8 $96 $54 $77.777 $32.65 138.21%
2022-11-04 9 $96 $54 $75.333 $32.65 130.73%
2022-11-15 9 $96 $54 $73.5 $32.65 125.11%
2022-12-21 9 $96 $50 $73.1 $32.65 123.89%
2023-01-05 9 $96 $50 $70.555 $32.65 116.09%
2023-01-06 9 $96 $50 $68.444 $32.65 109.63%
2023-01-17 9 $96 $50 $67.888 $32.65 107.93%
2023-01-31 9 $76 $50 $60.875 $32.65 86.45%
2023-02-10 9 $69 $50 $60 $32.65 83.77%
2023-02-14 9 $69 $50 $59.5 $32.65 82.24%
2023-03-01 10 $76 $50 $60.777 $32.65 86.15%
2023-04-20 10 $76 $50 $60.666 $32.65 85.81%
2023-05-01 10 $76 $50 $60.555 $32.65 85.47%
2023-05-05 10 $72 $50 $59.888 $32.65 83.42%
2023-07-04 10 $72 $50 $59.889 $32.65 83.43%
2023-07-13 10 $72 $50 $59.555 $32.65 82.4%
2023-07-21 9 $72 $50 $60.5 $32.65 85.3%
2023-07-25 9 $72 $48 $59.75 $32.65 83%
2023-08-03 9 $72 $48 $57.25 $32.65 75.34%
2023-08-09 9 $68 $46 $55.125 $32.65 68.84%
2023-10-13 9 $68 $46 $54.5 $32.65 66.92%
2023-10-23 10 $68 $46 $54.777 $32.65 67.77%
2023-11-03 10 $68 $42 $53.333 $32.65 63.35%
2023-11-06 10 $58 $42 $50.777 $32.65 55.52%
2023-11-07 10 $58 $38 $49.888 $32.65 52.8%
2023-11-28 10 $58 $38 $49.111 $32.65 50.42%
2023-12-20 11 $58 $38 $48.4 $32.65 48.24%

The Trend in the Analyst Price Target


PCRX's average price target has moved down $5.39 over the prior 43 months.

PCRX reports an average of 56.58% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-05 10 72 50 59.888 42.89 39.63%
2023-07-13 10 72 50 59.555 37.26 59.84%
2023-07-13 9 72 50 59.555 37.26 59.84%
2023-08-03 9 72 48 57.250 38.75 47.74%
2023-08-09 9 68 46 55.125 38.06 44.84%

PCRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.27 8 3 0 0 0 11

The Trend in the Broker Recommendations


Over the past 20 months, PCRX's average broker recommendation rating improved by 0.37.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PCRX as an investment opportunity.

  • PCRX has a higher upside potential (average analyst target price relative to current price) than 4626.08% of all US stocks.
  • In terms of how PACIRA BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 4519.39% of that group.
  • PACIRA BIOSCIENCES INC's number of analysts covering the stock is greater than 3983.23% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PACIRA BIOSCIENCES INC's variance in analysts' estimates is lower than -1734.98% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PACIRA BIOSCIENCES INC are EBS, SUPN, and PBH.

Is PCRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!